rethinkPeptides Search
Menu
Study breakdown

Bee Venom Peptides Made More Potent Against Breast Cancer Through Chemical Stapling

In VitroVery Low evidence
The takeaway

Hydrocarbon stapling of bee venom-derived panurgine peptides enhanced their stability and anti-breast cancer activity by overcoming protease degradation.

Enhanced by hydrocarbon stapling

Chemically stabilized bee venom peptides showed stronger anti-breast cancer activity than their natural linear forms

What the researchers found

Hydrocarbon stapling of panurgine peptides from bee venom enhanced their stability, cell membrane permeability, and anti-breast cancer efficacy compared to linear counterparts.

Why it matters

Natural anticancer peptides from venoms are promising but fragile. Stapling technology makes them viable drug candidates by solving the stability problem that has prevented clinical development.

The numbers in context

PNG-5 showed improved helicity, membrane permeability, proteolytic stability, and antitumor activity compared to unmodified panurgines.

How the study worked

Peptide synthesis of stapled panurgine variants using hydrocarbon stapling modifications, followed by testing of stability, cell penetration, and anti-breast cancer activity.

Who was studied

Breast cancer cell lines

What this study cannot tell us

In vitro study — anti-breast cancer activity was tested in cell cultures, not in animal models or humans. The stapled peptides'effect on healthy cells and in vivo toxicity remain to be assessed.

How to read the evidence

In vitro study demonstrating proof of concept. Anti-cancer activity in cell cultures needs validation in animal models and clinical testing.

When this study was published

Published in 2025, combining natural product discovery with modern peptide stapling technology.

The bigger picture

Venom-derived peptides are a rich but underexploited source of anticancer compounds. Stapling technology could unlock the therapeutic potential of many natural peptides that were previously too unstable for drug development.

Questions still open

  • How do stapled panurgines compare to current breast cancer chemotherapy agents in potency?
  • Can stapled panurgines selectively target cancer cells while sparing healthy tissue?

Common questions

Why are bee venom peptides being studied for cancer?
Panurgines from wild bee venom have natural ability to kill breast cancer cells and bacteria. Like many venom compounds, they evolved to disrupt cell membranes — a property that can be redirected against cancer cells.
What is hydrocarbon stapling?
Hydrocarbon stapling adds chemical bridges that lock a peptide into its active 3D shape, making it resistant to degradation by enzymes and better able to enter cells. This transforms fragile natural peptides into more drug-like molecules.

Read the original research

Leveraging the Therapeutic Potential of Natural Peptide Panurgines: Hydrocarbon Stapling Strategy Enhances Their Efficacy Against Breast Cancer.

Journal of peptide science : an official publication of the European Peptide Society, 31(10), e70047

Citation

Peng, Zhongzhong; Chen, Lei; Miao, Xianyuan; Wang, Qiongqiong; Fu, Shuyue; Zhang, Xikai; Zhou, Xiao; Ren, Sijia; Lao, Yehua; Li, Yinghua; Wang, Kaifeng; He, Shipeng. (2025). Leveraging the Therapeutic Potential of Natural Peptide Panurgines: Hydrocarbon Stapling Strategy Enhances Their Efficacy Against Breast Cancer.. Journal of peptide science : an official publication of the European Peptide Society, 31(10), e70047. https://doi.org/10.1002/psc.70047